Michael Minshall

Michael Minshall has a diverse work experience in the field of health economics and outcomes research. Michael is currently working as the Director of Health Economics and Outcomes Research at Zambon, where they are involved in designing and managing global HEOR programs for a new product in development. Michael'sresponsibilities include market access strategies and US reimbursement pathways.

Prior to their current role, Michael held the position of President and CEO at Strategic Consulting and Outcomes Research, Inc. from 2015 onwards. Michael provided management consulting services specializing in health economic assessments, economic modeling, and scientific communications for clients in the pharmaceutical, biotechnology, and medical device industries.

Before that, Michael held various positions at Sight Sciences, Inc., Certara, CTI Clinical Trial and Consulting Services, Humana, DJO Global, Covidien, IMS Health, and Eli Lilly. These roles involved conducting and managing HEOR projects, leading research studies, and providing health economic support and strategies for global business units.

Overall, Michael Minshall has extensive experience in health economics and outcomes research, with a strong focus on market access strategies and healthcare technologies.

Michael Minshall has a Bachelor of Science (B.S.) degree in Biology/Biological Sciences from Alma College. Additionally, they have a Master of Public Health (M.P.H) degree with a focus on Disease Control/Epidemiology from the University of Texas Health Science Center at Houston, School of Public.